OPKO Health, Inc., 10% Owner at GeneDx Holdings Corp. (WGS), sold 103,164 shares at $29.12 ($2.9M) on 2024-07-02, disclosed to the SEC on 2024-07-03.
Scheduled sale ($2.9M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.63 | 50,000 | $1.3M | 46.6% |
| 2 | $29.12 | 25,000 | $728K | 25.5% |
| 3 | $28.23 | 14,082 | $398K | 13.9% |
| 4 | $28.23 | 14,082 | $398K | 13.9% |
| Total | $27.67 avg | 103,164 | $2.9M | 100% |
| Filing → |
| WGS | SELL | 2024-08-08 | $3.9M | — | Filing → |
| WGS | SELL | 2024-08-02 | $6.0M | — | Filing → |
| WGS | SELL | 2024-07-31 | $1.7M | — | Filing → |